Last reviewed · How we verify
NCT05322798: HEAL-SCS
High-frequency SCS in Treatment of Chronic Limb-Threatening Ischemia
NA trial testing High-frequency SCS in Chronic Limb-Threatening Ischemia in 25 participants. Completed in 30 May 2021.
30 May 2020
Quick facts
| Lead sponsor | Meshalkin Research Institute of Pathology of Circulation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 12 August 2018 |
| Primary completion | 30 May 2020 |
| Estimated completion | 30 May 2021 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- High-frequency SCS
- Low-frequency SCS
Conditions studied
- Chronic Limb-Threatening Ischemia — all drugs for Chronic Limb-Threatening Ischemia →
Sponsor
Meshalkin Research Institute of Pathology of Circulation
Who can join
18 and older, any sex, with Chronic Limb-Threatening Ischemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study of high-frequency spinal cord stimulation (SCS) efficacy in the treatment of chronic limb-threatening ischemia (CLTI)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05322798
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Limb-Threatening Ischemia
Currently open trials in the same condition.
- NCT07352800 — Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-thr · Phase 2 · recruiting
- NCT06879561 — Pressure Wire Guidance for Infrapopliteal Artery Interventions · NA · recruiting
- NCT06071429 — Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease · NA · recruiting
- NCT06656364 — Esprit BTK Post-Approval Study · NA · active not recruiting
- NCT07330635 — Chronic Wounds and Blood Circulation Detection · NA · recruiting
Other Meshalkin Research Institute of Pathology of Circulation trials
Trials by the same sponsor.
- NCT07372196 — Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy · NA · recruiting
- NCT06443931 — Cryoablation of Intercostal Nerves for Pain Management in Early Postoperative Period in Patients With Minimally Invasive · NA · completed
- NCT06069115 — Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort · recruiting
- NCT05856461 — Pulmonary Artery Denervation in Patients With Atrial Fibrillation and Group 2 of Pulmonary Hypertension · NA · unknown
- NCT05643664 — The Role of Artificial Intelligence in the Treatment of Abdominal Aortic Aneurysms · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05322798 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Meshalkin Research Institute of Pathology of Circulation
- Last refreshed: 12 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05322798.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing